AstraZeneca to buy Bristol stake in diabetes venture for up to $4.1 billion

AstraZeneca has agreed to buy Bristol-Myers Squibb’s stake in a diabetes joint venture between the two drugmakers for an initial $2.7 billion plus up to $1.4 billion in additional payments. The move, announced …    

Leave a Reply

Your email address will not be published.